微信关注
Total item
Cart Subtotal
￥ 0.00 产品详情
RAF265 (CHIR-265)是一种口服，高度选择性的RAF和VEGFR激酶抑制剂，可控制或正常化VEGFR-2，同时抑制B-raf和c-Raf突变以预防癌症。
靶点信息
| VEGFR2 (Cell-free assay) | B-Raf (Cell-free assay) | |||
| 30 nM(EC50) | 3 nM-60 nM |
| In vitro (25°C) | DMSO | 85 mg/mL (163.96 mM) | |
| Water | Insoluble | ||
| Ethanol | 28 mg/mL (54.01 mM) | ||
| In vivo | 30% PEG400+0.5% Tween80+5% propylene glycol | 28 mg/mL | |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 19.29 mL | 96.45 mL | 192.9 mL |
| 0.5 mM | 3.86 mL | 19.29 mL | 38.58 mL |
| 1 mM | 1.93 mL | 9.65 mL | 19.29 mL |
| 5 mM | 0.39 mL | 1.93 mL | 3.86 mL |
*The above data is based on the productmolecular weight 518.4 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| 目录号 | A10773 |
|---|---|
| 作用机制 | Inhibitor (抑制剂) |
| M. Wt | 518.4 |
| Formula | C24H16F6N6O |
| Purity | >99% |
| Storage | Store lyophilized at -20ºC, keep desiccated. |
| CAS No. | 927880-90-8 |
| SMILES | CN1C2=C(C=C(C=C2)OC3=CC(=NC=C3)C4=NC=C(N4)C(F)(F)F)N=C1NC5=CC=C(C=C5)C(F)(F)F |
产品标签
Product Questions
Product Questions
No Questions
您还可能对下列产品感兴趣
Bibf1120 (Nintedanib)
Bibf1120 (Nintedanib)是一种新型的三联血管激酶抑制剂，可同时抑制三种生长因子受体：VEGFR，PDGF和FGFR。
Motesanib Diphosphate (AMG-706)
Motesanib也称为AMG-706，是一种有效的ATP竞争性的VEGFR1/2/3抑制剂，IC50分别为2 nM/3 nM/6 nM；对Kit具有相似的抑制…
SU 5416 (Semaxinib)
SU 5416 (Semaxinib)是血管内皮生长因子受体（VEGFR）的抑制剂，它还抑制其他酪氨酸激酶KIT，MET，FLT3和RET。
RO5126766 (CH5126766)
RO5126766 (CH5126766)是对Raf和MEK丝裂原激活的蛋白激酶（MAPK）具有特异性的蛋白激酶抑制剂，具有潜在的抗肿…
Imatinib (Gleevec)
Imatinib (Gleevec)是一种多靶点酪氨酸激酶抑制剂，抑制v-Abl、c-Kit和PDGFR的IC50分别为0.6，0.1和0.1 μM。
Linifanib (ABT-869)
Linifanib (ABT-869)是一种结构新颖的有效RTK，VEGF和PDGF抑制剂，对人内皮细胞，PDGFR-β，KDR和CSF-1R的IC50分别为0.…
Dabrafenib (GSK2118436A)
Dabrafenib (GSK2118436A)是一种有效且选择性的B-RAF蛋白激酶抑制剂，具有V600E突变，目前正在临床试验中。
LGX 818 (Encorafenib)
LGX 818 (Encorafenib)是一种Raf激酶抑制剂，具有潜在的抗肿瘤活性。
Keywords:购买 RAF265 (CHIR-265) | RAF265 (CHIR-265) 供应商 | 订购 RAF265 (CHIR-265) | RAF265 (CHIR-265) 价格 | RAF265 (CHIR-265) 生产商 | 订单 RAF265 (CHIR-265) | RAF265 (CHIR-265) 代理商 | 购买 927880-90-8| 927880-90-8 供应商 | 订购 927880-90-8 | 927880-90-8 价格 | 927880-90-8 生产商 | 订单 927880-90-8 | 927880-90-8 代理商|buy RAF265 (CHIR-265) | RAF265 (CHIR-265) Supplier | purchase RAF265 (CHIR-265) | RAF265 (CHIR-265) cost | RAF265 (CHIR-265) manufacturer | order RAF265 (CHIR-265) | RAF265 (CHIR-265) distributor | buy 927880-90-8| 927880-90-8 Supplier | purchase 927880-90-8 | 927880-90-8 cost | 927880-90-8 manufacturer | order 927880-90-8 | 927880-90-8 distributor